loperamide and (2s,3s)-2-phenyl-3-((5-trifluoromethoxy-2-methoxy)benzylamino)piperidine

loperamide has been researched along with (2s,3s)-2-phenyl-3-((5-trifluoromethoxy-2-methoxy)benzylamino)piperidine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashton, C; Gonsalves, S; Watson, J1

Other Studies

1 other study(ies) available for loperamide and (2s,3s)-2-phenyl-3-((5-trifluoromethoxy-2-methoxy)benzylamino)piperidine

ArticleYear
Broad spectrum antiemetic effects of CP-122,721, a tachykinin NK1 receptor antagonist, in ferrets.
    European journal of pharmacology, 1996, Jun-03, Volume: 305, Issue:1-3

    Topics: Animals; Antiemetics; Cisplatin; Copper Sulfate; Emetics; Ferrets; Ipecac; Loperamide; Male; Neurokinin-1 Receptor Antagonists; Piperidines; Stereoisomerism; Vomiting

1996